Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management

Fig. 1

Possible mechanisms of COVID-19-associated liver injury in MAFLD patients, including the direct effect of the virus on hepatocytes, disruption of cholangiocyte function, whole-body hyperinflammation and dysregulated immune responses, abnormal coagulation and thrombosis, drug-induced liver injury, hepatic ischemia and hypoxia-reperfusion dysfunction, and the exacerbation of preexisting liver disease (including MAFLD)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X